D-(−)-Citramalic acid lithium salt is primarily utilized in biochemical research and pharmaceutical development. It serves as a key intermediate in the synthesis of various organic compounds, particularly in the production of chiral molecules. Its application extends to the study of enzymatic reactions and metabolic pathways, where it acts as a substrate or inhibitor to understand enzyme mechanisms. Additionally, it is employed in the development of lithium-based drugs, leveraging its lithium content for potential therapeutic effects in neurological and psychiatric disorders. Its role in asymmetric synthesis also makes it valuable for creating enantiomerically pure substances, which are crucial in the production of high-purity pharmaceuticals.